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Abstract Interactions between a benzimidazolic
derivative, omeprazole (OME), beta-cyclodextrin
(bCD) and a chemically modified bCD, methyl-beta-
cyclodextrin (MbCD) were investigated in aqueous
solution by UV-VIS spectroscopy and in solid state by
differential scanning calorimetry (DSC). Phase solu-
bility studies were used to evaluate the complexation in
aqueous solution. The two solubility diagrams obtained
were AL type, indicating the formation of a drug-
cyclodextrin complex with 1:1 stoichiometry. The
complex of OME with MbCD showed a higher stability
constant (KS) than those with bCD. Some evidences of
inclusion complexation in solid state were obtained
from DSC. Only in thermal curves of OME-bCD
lyophilized product and in OME-MbCD spray-dried
and lyophilized systems the melting point of the drug
disappeared completely suggesting the possible for-
mation of an inclusion complex.
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Introduction
Omeprazole (OME) is a substituted benzimidazole
that inhibits gastric acid secretion by covalently bind-
ing to the proton pump (H+/K+ ATPase) at the surface
of gastric parietal cells, which inhibit the final step in
secretion of the hydrogen ions into the gastric lumen
[1]. However, OME is sparingly soluble in water and
shows a low physicochemical stability. This poor
aqueous solubility of the drug gives rise to difficulties
in the pharmaceutical formulation. To overcome this
drawback, the increase of the aqueous solubility of
OME is very important.
The potential use of natural cyclodextrins (CDs) and
their synthetic derivatives has been extensively studied
to improve certain drug properties such as solubility,
stability, and/or bioavailability. The property of
enhancing solubility may be explained by the formation
of water-soluble ‘‘inclusion complexes’’ in which the
hollow, truncated, cone-like CD structure encapsulates
the hydrophobic drug molecules in the apolar interior.
In contrast, the outer, hydrophilic region of the CD
enables the solubilization through interaction with
water molecules [2]. Nevertheless, natural CDs have
limited water solubility. In order to obtain a significant
increase in water solubility, some chemically deriva-
tives have been synthesized by derivatization of the free
hydroxyl groups of the CDs with alkyl and sulfobutyl
groups resulting in hydroxyalkyl, methyl, and sulfobutyl
derivatives with higher water solubility [3].
In a thorough study of an inclusion complex, phase
solubility studies are the first tool to provide evidence of
an inclusion complex formation in solution. At the solid
state, the subsequent phases of inclusion complex char-
acterization may be provided by differential scanning
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calorimetry (DSC), X-ray powder diffraction, Fourier
transformation infrared spectroscopy. Thermal analysis
is commonly used as a routine method for a rapid pre-
liminary qualitative investigation by comparing the
thermal behavior of single components, their physical
mixture and the inclusion compound candidate pre-
pared according to a variety of standard procedures [4].
The aim of this work was to investigate the forma-
tion of an inclusion complex between omeprazole, a
poorly water soluble drug, and b-cyclodextrin (bCD)
or its amorphous derivative methyl-b-cyclodextrin
(MbCD), in solution by phase solubility studies and in
solid state by DSC.
Materials and methods
Chemicals
bCD (Lot 768237; MW = 1135) and MbCD (Lot
768240; MW = 1190 with an average degree of substi-
tution DS = 0.5) were a gift from Roquette (Lestrem,
France). OME (Lot 18104; MW = 345.42) was kindly
donated by Belmac Laboratory, S.A. (Barcelona,
Spain). All other reagents were of the highest purity
available from commercial sources.
Phase solubility studies
Phase solubility studies were carried out at room
temperature (21 ± 1C) according to the method of
Higuchi and Connors [5]. Excess amounts of OME
were weighted in glass flasks to which were added
10 mL of boric/borate buffer pH = 10 ± 0.1 containing
increasing amounts of bCD (0–1.5%, w/v) or MbCD
(0–5%, w/v). Glass containers were sealed and
mechanically stirred, protected from light until reach-
ing the equilibrium (about 96 h). All suspensions were
filtered through a 0.45 lm membrane filter (Millipore)
and analyzed spectrophotometrically (UV-1603, Shi-
madzu, Japan) at 305.5 nm.
The apparatus was calibrated with the correspond-
ing blank for each assay and three replicates were
made. KS were calculated from the straight line of the
phase solubility diagrams using the equation:
KS = slope / intercept (1 - slope)
Preparation of solid binary systems
The preparation of OME:bCD and OME:MbCD solid
systems was performed by different techniques, namely
by kneading, spray-drying and freeze-drying in a molar
ratio of 1:1. Physical mixtures were prepared as refer-
ences to perform comparative evaluations with the
respective solid inclusion complexes.
Physical binary mixtures (PM)
PMs were prepared by homogeneous blending in a
mortar of previously sieved (63–160 lm sieve granu-
lometric fraction) and weighted OME and CDs (bCD
and MbCD).
Kneaded binary products (KN)
CDs were wetted in a ceramic mortar with a basic
aqueous solution of pH = 10 ± 0.1 until a paste was
obtained (about 30% of the total weight). The required
amount of OME was then slowly added and the slurry
was kneaded for 45 min. During this process, an
appropriate volume of a basic aqueous solution
(pH = 10) was added in order to maintain a suitable
consistency and to avoid OME degradation. The final
product was then allowed to equilibrate at room tem-
perature for 48 h protected from light.
Spray-dried binary products (SD)
Equimolar amounts of OME and CDs were dissolved
in ethanol and basic aqueous solution (hydro-alcoholic
solution 2:1), respectively. Both solutions were mixed
and stirred for 24/48 h, being the pH of the solutions
adjusted during the process to avoid the possible OME
degradation. Solutions were subsequently spray-dried
in a LabPlant SD-05, under the following conditions:
inlet temperature 102C, outlet temperature 60–65C,
flow rate of the solution 400 mL/h, airflow rate
40–50 m3/h and atomizing air pressure 1.0–1.1 bar. [6].
Lyophilized binary products (LPh)
An appropriate amount of CDs was dissolved to a
basic aqueous solution (pH = 10 ± 0.1). After that,
OME was added to this solution under stirring,
according to the stoichiometry 1:1. The suspension
stirring was maintained for 24/48 h. Furthermore, the
resultant clear solutions were frozen by immersion in
an ethanol bath at –50 C (Shell Freezer, Labconco,
Freezone model 79490) and then the frozen solutions
were lyophilized in a freeze-dryer (Lyph-lock 6 appa-
ratus, Labconco) for 72 h.
The obtained powders were sieved (63–160 lm) and
their drug content was determined by UV assay at
305.5 nm.
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Differential scanning calorimetry
DSC measurements of the pure materials (OME and
CDs) and binary systems were carried out using a
Shimadzu DSC-50 System (Shimadzu, Kyoto, Japan)
with a DSC equipped with a computerized data station
TA-50WS/PC. The thermal behaviour was studied by
heating the samples in a sealed aluminium pan from
25C to 250C, at a rate of 10C/min and under a
nitrogen flow of 20 cm3/min., using an empty pan
sealed as reference. Indium (99.98%, mp 156.65C,
Aldrich, Milwaukee, USA) was used as standard for
calibrating the temperature.
Results
Phase solubility studies
Phase solubility studies of OME with bCD and MbCD
are shown in Fig. 1. OME solubility increased linearly
over the entire concentration range studied with both
CDs concentrations, indicating the formation of AL
type diagrams. The slope values were in both diagrams
less than one suggesting the formation of 1:1 stoichi-
ometry complexes in solution. The OME solubility was
enhanced 1.6 and 3.6 times in the presence of bCD and
MbCD, respectively, in comparison with OME solu-
bility in buffer borate (see Fig. 2). The KS of the
inclusion complexes were 57 and 77 M–1 for bCD and
MbCD, respectively. Values of OME solubility with
and without CDs are collected in Table 1. The low
magnitude of these stability constants indicated a weak
interaction between the drug (OME) and both CDs. In
fact at pH = 10, to assure drug stability, OME is in the
ionized form. However, drug ionization greatly reduces
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Fig. 1 Phase solubility studies of OME with CDs: bCD (A) and
MbCD (B). Each point represents the mean of three determi-
nations
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Fig. 2 OME solubility in borate buffer ( ) and OME
solubility in CDs solutions [1.5% (w/v) bCD and 5% (w/v)
MbCD], ( ). (1) bCD and (2) MbCD
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Fig. 3 DSC thermograms of OME:bCD (A) and OME:MbCD
(B) inclusion complexes. Omeprazole (OME), b-cyclodextrin
(bCD), methyl-b-cyclodextrin (MbCD), physical mixture (PM),
kneaded (KN), spray dried (SD) and lyophilized (LPh) systems
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the magnitude of complex formation lowering KS
values. Since, ionization is a common method for
increasing the aqueous solubility of ionizable drugs, the
additional drug solubilization by CDs may result in the
improvement of drug solubility, by solubilization of a
drug both due to CD complexation and ionization [7].
Differential scanning calorimetry
The DSC profiles of pure components (OME, bCD
and MbCD) and binary systems in the melting region
of the drug and carriers dehydration are shown in
Fig. 3. The thermal curve of OME was typical of a
crystalline anhydrous substance with a sharp fusion
endotherm at 159.8 C, corresponding to the melting
point of the drug, followed by an exothermal effect at
173.9 C, attributed to its thermal decomposition [8].
The DSC curves of bCD and MbCD showed a broad
endothermic effect around 85 C and 64 C, respec-
tively, associated to crystal water losses from CDs [9].
In PM DSC curves it was clearly distinguishable OME
endothermic peak around 159.81–160.05 C in addition
to the CDs dehydration effect. These curves are in fact
the DSC curves superpositions of the individual
components [10], showing the absence of interaction
between the drug and CDs in such systems.
Considering KN systems, there was a substantial size
reduction, broadening and a shift to lower tempera-
tures of the drug melting point (149.5 C and 145.7 C
for bCD and MbCD, respectively). This effect, spe-
cially observed for OME:MbCD KN product, could be
ascribed to some drug-CD interaction [11]. This fact
was also observed in OME:bCD SD system. In these
systems we can assume the occurrence of a reduction in
drug crystallinity or probably a partial dispersion at a
molecular level at the solid product [12], but this was
not indicative of a true inclusion complex formation.
Oppositely, the disappearance of the OME melting
point in the OME:MbCD SD system and in both LPh
products suggest the formation of amorphous solid
dispersion and/or inclusion complexes [13]. These
results are a strong evidence that only OME:MbCD
SD system and LPh products can be considered true
inclusion complexes.
Conclusions
Those preliminary results suggest that OME forms
inclusion complexes with bCD and MbCD in aqueous
solution with a 1:1 stoichiometry. Furthermore, KS
values indicate that the derivative of bCD (MbCD)
formed a more stable inclusion complex with OME
than those with bCD, probably because the higher
cavity hydrophobicity of MbCD comparatively to bCD
cavity. OME solubility increased by CD complexation
being this effect more pronounced with MbCD. The
physicochemical solid-state characterization of
OME:bCD and OME:MbCD inclusion complexes by
DSC and other experimental data, as yet not pub-
lished, indicated the presence of new solid phases,
some of them in an amorphous state and gave strong
evidence of the formation of inclusion complexes
between OME and CDs (bCD and MbCD) particu-
larly for OME:MbCD spray dried system and lyophi-
lized products for both CDs.
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